Over-expression of CO-2 in breast cancer has been reported to reduce survival [5], [7], [15], [16], not impact survival [12], [15], [16], [17], [18], reduce survival when associated with high Ki-67 levels [19], [20], and improve survival when associated with low Ki-67 levels [20]. The gene discussed is MKI67; the disease is breast cancer.